Xentria Inc. Transforming Industries with Transformative Solutions

Sponsor: Xentria, Inc. Overall Status: Active - Recruiting. Phase. 1/2. Condition. Sarcoidosis. Lung Disease. Treatment. XTMAB-16 or Placebo ... Xentria Investigative Site. Budapest, Hungary, 1077. Enrolling. Contact site. Central trial contact. Xentria Inc. Xentria Inc. Contact trial ... Concern for Independent Living, Inc. is a non-profit agency committed to ... Xentria. Phone. Email. Profile Picture · Donna Shea. Executive Program Director. ... Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was established in April 2020. Victoria came to Meitheal from Sagent ... CHICAGO, IL June 27, 2023: Xentria Inc., a clinical-stage biotherapeutics company focused on developing therapeutics to address unmet clinical needs, ... Vice President, Clinical Development - Xentria, Inc. · Solutions-focused clinical development professional with a diverse background in patient care, ... https://www.xentria.com/. LinkedIn. https://www.linkedin.com/company/xentria-inc/. Telephone. +1 224-443-4615. Address. 8700 W Bryn Mawr Ave Ste 600S Chicago, ... CHICAGO, Dec. 19, 2024 /PRNewswire/ -- Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development ... Denosumab Biosimilar(Xentria): a RANKL inhibitors Drug, Initially developed by Xentria, Inc., Now, its global highest R&D status is Phase 3, ... Key Sarcoidosis Companies: Pfizer, United Therapeutics, Xentria, Inc., aTyr Pharma, Inc., Kyorin Pharmaceutical Co., Ltd, Novartis, Kinevant Sciences GmbH ...